V3: Salanci, Š.; Vilková, M.; Martinez, L.; Mirossay, L.; Michalková, R.; Mojžiš, J. The Induction of G2/M Phase Cell Cycle Arrest and Apoptosis by the Chalcone Derivative 1C in Sensitive and Resistant Ovarian Cancer Cells Is Associated with ROS Generation. Int. J. Mol. Sci. 2024, 25, 7541, Q1, IF 5,7. https://doi.org/10.3390/ijms25147541

V3: Sokoli, L., Takáč, P., Budovská, M., Michalková, R., Kello, M., Nosálová, N., Balážová, Ľ., Salanci, Š., & Mojžiš, J. (2025). The Proapoptotic Effect of MB-653 Is Associated with the Modulation of Metastasis and Invasiveness-Related Signalling Pathways in Human Colorectal Cancer Cells. Biomolecules, 15(1), 72, Q1, IF 5,6. https://doi.org/10.3390/biom15010072

V3: Huniadi, M., Salanci, S., Sykora, J., Kurhajec, S. & Sarissky, M. (2022). Optimisation of flow cytometric detection of intracellular SLAMF receptor-associated adaptor proteins SAP and EAT-2. European Pharmaceutical Journal, 69(s1), 2022. 87-89. https://doi.org/10.2478/afpuc-2022-0007

V2: Salanci Š., Vilková M., Martinez L., Mirossay L., Michalková R., Mojžiš J. – Chalcone 1C as a mediator of ROS-associated cell death in ovarian cancer – 72nd Czech-Slovak Pharmacological Days Abstract Book – 2025 – s. 66 – ISBN: 978-80-574-0420-0.

V2: Salanci Š., Huniadi M., Kľoc D., Sýkora J., Šarišský M. – Detection of circulating myeloma cells by NGF cytometry – Contribution in the Proceedings of Jarná škola doktorandov 2023, 9th edition – 2023 – pp. 111–117 – ISBN: 978-80-574-0212-1.

VEGA1/0617/22 - SLAMF receptors in chronic lymphocytic leukemia - potential targets of anticancer therapy. - PharmDr. Marek Šarišský, PhD